All of the above-mentioned studies were performed with cells that have more severe perturbations in functional RUNX1 than would be expected with the mono-allelic mutations in FPD/AML, and the DNA repair and apoptotic defects are likely to be more profound in experimental models. Here, RUNX1 is linked to acute myeloid leukemia.